Transcription of Molecular Diagnostic Infectious Disease Testing
{{id}} {{{paragraph}}}
Example: barber
Molecular Diagnostic Infectious Disease Testing
Molecular Diagnostic Infectious Disease Testing Page 1 of 23 UnitedHealthcare Medicare Advantage Policy Guideline Approved 01/12/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Medicare Advantage Policy Guideline Molecular Diagnostic Infectious Disease Testing Guideline Number: Approval Date: January 12, 2022 Terms and Conditions Table of Contents Page Policy Summary .. 1 Applicable Codes .. 3 Questions and Answers .. 19 References .. 19 Guideline History/Revision Information .. 22 Purpose .. 23 Terms and Conditions .. 23 Policy Summary See Purpose Overview Molecular Diagnostic Testing , which includes Deoxyribonucleic Acid-(DNA) or Ribonucleic Acid-(RNA) based analysis (with or without amplification/quantification) provides sensitive, specific and timely ( , relative to that of traditional culture-based methods) identification of diverse biological entities, including microorganisms and tumors.
service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: